Why is Sakar Healthcare falling/rising?

As of 12-Sep, Sakar Healthcare Ltd's stock is currently priced at 334.30, reflecting a decline of 7.0 points or 2.05%. The stock has underperformed its sector today by 2.34%, although it remains higher than the 20-day, 100-day, and 200-day moving averages. Over the past week, the stock has gained 0.59%, while its performance over the last month shows a modest increase of 1.12%. Despite a strong performance in the long term, with a year-to-date return of 12.77%, the recent decline may be influenced by its high valuation metrics, including a ROCE of 8.35% and a PEG ratio of 0.5, suggesting that the stock may be perceived as expensive relative to its growth potential.
In the broader market context, the Sensex has increased by 1.51% over the past week, indicating that Sakar Healthcare's recent decline is occurring against a backdrop of positive market performance. While the stock has shown resilience with a 53.67% return over the last three years, the current downturn may reflect investor concerns regarding its long-term growth prospects, particularly given the annual operating profit growth rate of 18.78% over the past five years. The high institutional holdings at 24.66% suggest that informed investors are closely monitoring the company's fundamentals, which could also contribute to the stock's volatility in response to market conditions.